Navigation Links
New animal model may lead to treatments for common liver disease
Date:7/3/2012

Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation afflicting up to 15 million Americans and for which there is no cure.

The condition, nonalcoholic steatohepatitis (NASH), resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. The major feature of NASH is accumulation of fat in the liver, along with inflammation and functional damage. Most people with NASH feel well and are not aware that they have a liver problem. Nevertheless, NASH can progress to cirrhosis, in which the liver is permanently damaged and no longer able to work properly. NASH-related cirrhosis is the fourth most common indication for liver transplantation in the U.S.

NASH affects 2 to 5 percent of Americans roughly six million to 15 million people. An additional 15 to 30 percent of Americans have excess fat in their livers, but no inflammation or liver damage, a condition called "fatty liver" or the non-progressive form of nonalcoholic fatty liver disease (NAFLD).

The study, published in the July issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology, was supported by the National Institutes of Health and the Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation.

"This is the type of model in which to develop mechanism-based therapies," writes Geoffrey C Farrell, M.D., of the Australian National University Medical School in Canberra, in a journal editorial.

Both NASH and NAFLD are becoming more common, possibly because of the greater number of Americans with obesity and its important health complications, type 2 diabetes, high blood cholesterol levels, high blood pressure and other risk factors for heart attack and stroke. In the past 10 years, the prevalence of obesity has doubled in adults and tripled in children. It was previously reported by other scientists that the prevalence of NAFLD and NASH in a cohort of middle-aged patients in San Antonio is 46 percent and 12 percent, respectively.

"It now seems likely that genetic factors, such as those important for diabetes and high cholesterol levels, are what determines why a small proportion of those with fatty liver develop NASH and its complications of cirrhosis and liver cancer," said Farrell.

In the new study, high responding opossums developed elevated cholesterol and fatty liver disease when fed a high cholesterol and high fat diet, whereas low responding opossums did not. High responders carry a mutated ABCB4 gene, which affects their ability to secrete excess cholesterol from the liver into bile which, in turn, transports the cholesterol to the intestines for excretion from the body. As a consequence, opossums with the mutated gene accumulate cholesterol in the liver and ultimately in the blood.

"We showed that the fatty livers of high responders contain a tremendous amount of cholesterol," said first author Jeannie Chan, Ph.D., of Texas Biomed. "The opossum is a new animal model for investigating the mechanism by which cholesterol mediates liver injury, which will lead to a better understanding of the role of dietary cholesterol in the development of NASH."


'/>"/>

Contact: Joseph Carey
jcarey@txbiomed.org
210-258-9437
Texas Biomedical Research Institute
Source:Eurekalert

Related medicine news :

1. Potential treatment target identified in an animal model of pancreatic cancer
2. New technique could reduce number of animals needed to test chemical safety
3. Chicago Dog Bite Injury Lawyers Advise Dog Owners To Get Control of Their Animals, Or Be Prepared To Pay Up
4. Woodbridge Animal Hospital Unleashes New Pet Care Website
5. Recruiting for Good Launches Pet Philanthropy Program to Collaboratively Fundraise for Kitt Crusaders an Animal Rescue Organization
6. Raucous Music May Tap Into Your Inner Animal
7. Animals More Interesting to Kids Than Toys, Study Shows
8. FDA Seeks to Limit Antibiotics in Animal Feed
9. Researchers develop a new cell and animal model of inflammatory breast cancer
10. DeNova Homes at Southgate, Announces Single Story Model Opening
11. Human model of Huntingtons disease created from skins stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... Standards Consortium (CDISC) announces today the open availability of a new CDISC ... and catalogs for registering clinical trials. This innovative standard will make it ...
(Date:4/28/2016)... & WASHINGTON, D.C., (PRWEB) , ... April 28, ... ... Catholic health systems, and the Campaign for Tobacco-Free Kids, a leading force in ... partnership to promote federal, state and local policies that can help reduce tobacco ...
(Date:4/28/2016)... ... ... In 2011, TIME magazine named Herr the “Leader of the Bionic Age”, ... human physiology with electromechanics. He continues that work as Director of the Biomechatronics research ... , a leader in the field of prosthetic devices. , After a blizzard during ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cognizin® Citicoline is one ... Nominated in the Healthy Ageing category, Cognizin® is being considered for this prestigious ... division can include everything from antioxidants, lipids, proteins, and botanicals. NutraIngredients will choose ...
(Date:4/28/2016)... ... 2016 , ... USA Medical Card reminds us that May is National Stroke Awareness Month. ... leading cause of death in the United States; someone has one every 40 seconds. ... individuals under 65 years old. A stroke is when blood flow to the brain ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  While Abbott,s announced purchase of ... valve repair and stent business, healthcare research firm ... more firmly into patient monitoring.  Kalorama said that ... device areas, with double-digit growth expected the next ... Advanced Remote Patient Monitoring . Abbott Laboratories ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
(Date:4/28/2016)... , April 28, 2016  ValGenesis, Inc., ... Management Solutions (VLMS) today announced that a ... for sufferers of chronic kidney failure has ... manage their corporate validation process. The global ... software solution to manage their validation processes ...
Breaking Medicine Technology: